Condition

Alzheimer Disease (3)

Alzheimer's Disease (1)

Cardiac Amyloidosis (1)

Dementia (1)

Early Onset Alzheimer Disease (1)

Mild Cognitive Impairment (1)

Overall Status

Recruiting (3)

Completed (1)

Enrolling by invitation (1)

Phase

early phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Jose Gutierrez, MD, MPH (1)

Liana Apostolova (1)

University of Pennsylvania (1)

William Charles Kreisl (1)

Yaakov Stern (1)

Collaborator

National Institute on Aging (NIA) (2)

Alzheimer's Association (1)

Alzheimer's Therapeutic Research Institute (1)

Intervention

florbetaben (5)

11c-er176 (2)

[f-18]mk-6240 (1)

flortaucipir (1)

fluorodeoxyglucose (1)

fnos (1)

magnetic resonance imaging (1)

Study Documents

Intervention Type

drug (5)

other (1)

Funder Type

Other (5)

Study Type

Observational (3)

Interventional (2)

florbetaben

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Accelerated Non-Atherosclerotic Brain Arterial Aging

Recruiting

Alzheimer Disease
Dementia

11C-ER176
+3 more

New York, New York

Columbia University Medical Center

Jan 11, 2022

Cardiac Amyloidosis Trial in Philadelphia (FNOS, Florbetaben)

Recruiting

Cardiac Amyloidosis

FNOS
Florbetaben

Philadelphia, Pennsylvania

University of Pennsylvania

Sep 24, 2021

Alzheimer Trial in New York (11C-ER176, Florbetaben)

Enrolling by invitation

Alzheimer Disease

11C-ER176
Florbetaben

New York, New York

Columbia University Medical Center

Aug 4, 2021

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Recruiting

Early Onset Alzheimer Disease
+2 more

Flortaucipir
+2 more

Sun City, Arizona
+18 more

Mar 15, 2022

Imaging of Cognition, Learning, and Memory in Aging

Completed

Alzheimer's Disease

Florbetaben

New York, New York

Columbia University Medical Center

Oct 30, 2017